388 related articles for article (PubMed ID: 16026425)
1. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Smelov V; Perekalina T; Artemenko N; Smelova N; Ukleeva G; Gorelov A
Andrologia; 2005 Jun; 37(2-3):61-4. PubMed ID: 16026425
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
[TBL] [Abstract][Full Text] [Related]
3. Clinical and microbiological efficacy of prulifloxacin for the treatment of chronic bacterial prostatitis due to Chlamydia trachomatis infection: results from a prospective, randomized and open-label study.
Cai T; Mazzoli S; Addonisio P; Boddi V; Geppetti P; Bartoletti R
Methods Find Exp Clin Pharmacol; 2010; 32(1):39-45. PubMed ID: 20383345
[TBL] [Abstract][Full Text] [Related]
4. Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
Magri V; Marras E; Skerk V; Markotić A; Restelli A; Garlaschi MC; Perletti G
Andrologia; 2010 Dec; 42(6):366-75. PubMed ID: 21105887
[TBL] [Abstract][Full Text] [Related]
5. Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
J Chemother; 2007 Jun; 19(3):304-8. PubMed ID: 17594926
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
[TBL] [Abstract][Full Text] [Related]
7. Single-drug or combined antibacterial therapy in the treatment of patients with chronic prostatitis and Chlamydia trachomatis?
Smelov V; Gorelov A; Smelova N; Krylova T
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S83-7. PubMed ID: 15037333
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial therapy for chronic bacterial prostatitis.
Perletti G; Marras E; Wagenlehner FM; Magri V
Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.
Smelov V; Krylova T; Smelova N; Norman L
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S79-82. PubMed ID: 15037332
[TBL] [Abstract][Full Text] [Related]
10. May Chlamydia trachomatis be an aetiological agent of chronic prostatic infection?
Ouzounova-Raykova V; Ouzounova I; Mitov IG
Andrologia; 2010 Jun; 42(3):176-81. PubMed ID: 20500746
[TBL] [Abstract][Full Text] [Related]
11. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
Cao W; Liu L; Tong MH
Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):177-9. PubMed ID: 12934372
[TBL] [Abstract][Full Text] [Related]
12. Role of Chlamydia trachomatis in chronic prostatitis: diagnostic investigation and therapeutic experience with miocamycin.
Rossi R; Mora A
J Chemother; 1989 Jul; 1(4 Suppl):913-5. PubMed ID: 16312701
[No Abstract] [Full Text] [Related]
13. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
14. Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.
Skerk V; Krhen I; Lisić M; Begovac J; Roglić S; Skerk V; Sternak SL; Banaszak A; Strugar-Suica J; Vuković J
Int J Antimicrob Agents; 2004 Aug; 24(2):188-91. PubMed ID: 15288321
[TBL] [Abstract][Full Text] [Related]
15. Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
Jeong CW; Lim DJ; Son H; Lee SE; Jeong H
Urol Int; 2008; 80(2):157-61. PubMed ID: 18362485
[TBL] [Abstract][Full Text] [Related]
16. Antichlamydial antibodies in the serum and expressed prostatic secretion in prostatitis.
Ostaszewska-Puchalska I; Zdrodowska-Stefanow B; Badyda J; Bułhak-Kozioł V; Puciło K; Darewicz B
Arch Immunol Ther Exp (Warsz); 2004; 52(4):277-83. PubMed ID: 15467492
[TBL] [Abstract][Full Text] [Related]
17. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of a new quinolone, NM 394, against Chlamydia trachomatis].
Poutiers F; de Barbeyrac B; Garcia-Mace J; Bebear C
Pathol Biol (Paris); 1996 May; 44(5):351-4. PubMed ID: 8758474
[TBL] [Abstract][Full Text] [Related]
19. The role of Chlamydia trachomatis in prostatitis syndrome--our experience in diagnosis and treatment.
Skerk V; Krhen I; Cajić V; Markovinović L; Puntarić A; Roglić S; Zekan S; Ljubin-Sternak S; Zidovec Lepej S; Vince A
Acta Dermatovenerol Croat; 2007; 15(3):135-40. PubMed ID: 17868538
[TBL] [Abstract][Full Text] [Related]
20. The role of Chlamydia trachomatis in patients with non-bacterial prostatitis.
Mutlu N; Mutlu B; Culha M; Hamsioglu Z; Demirtas M; Gökalp A
Int J Clin Pract; 1998; 52(8):540-1. PubMed ID: 10622051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
